<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effectiveness and side effects of a <z:chebi fb="14" ids="39867,4640,53488">DPA</z:chebi> monotherapy were evaluated in 96 children and adolescents over a period of five years </plain></SENT>
<SENT sid="1" pm="."><plain>In addition the attempt has been made to find correlations between sex, age of <z:hpo ids='HP_0001250'>seizure</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo>, etiology of the disease, types of <z:hpo ids='HP_0001250'>seizures</z:hpo>, and <z:hpo ids='HP_0002353'>EEG abnormalities</z:hpo> on the one hand, and the clinical response to the drug on the other hand </plain></SENT>
<SENT sid="2" pm="."><plain>The results are in many respects similar to other observations with <z:chebi fb="14" ids="39867,4640,53488">DPA</z:chebi>: good therapeutic effect in cases with <z:hpo ids='HP_0001250'>seizure</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> between the age of 7-10 years, cryptogenic or genetic etiology, primary <z:hpo ids='HP_0002197'>generalized seizures</z:hpo>, and a generalized pattern in EEG (without focal changes) </plain></SENT>
<SENT sid="3" pm="."><plain>On the contrary positive effect of <z:chebi fb="14" ids="39867,4640,53488">DPA</z:chebi> in <z:e sem="disease" ids="C0014547" disease_type="Disease or Syndrome" abbrv="">partial epilepsies</z:e> and secondarily <z:e sem="disease" ids="C0014548" disease_type="Disease or Syndrome" abbrv="">generalized epilepsies</z:e> was seen only in those patients who had a <z:hpo ids='HP_0001250'>seizure</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> between seven and ten years and a cryptogenic etiology (syndrome of <z:e sem="disease" ids="C0376532" disease_type="Disease or Syndrome" abbrv="BECTS">benign rolandic epilepsy</z:e> in childhood can be suspected in these cases) </plain></SENT>
</text></document>